Abstracts
- Submission Overview
- Detailed Submission Guidelines
- Late breaking abstracts
- FAQs
Submission Overview

Call for abstracts open
Abstract Submission Deadline
Any abstracts received after this date will not be accepted
Abstracts notifications sent
Deadline for withdrawal and to request modifications
Late Breaking Abstract Submission Opens
Early bird deadline
Late Breaking Abstract Submission deadline
Deadline to submit PDF posters for app
Late Breaking Abstracts notifications sent
Abstract submission conditions
Please read the instructions below before starting to submit your abstract(s) for consideration.
- The abstracts must be submitted through the online submission portal and must only be submitted once.
- The person who submits the abstract will be the main contact for it. That person must create an account to upload, edit and save the abstract(s) in the portal. Please keep the email and password used to create the account for future use. Please do not create a new account each time you enter the portal.
- Submissions should ideally be original. However, we can accept abstracts that have been presented at an International meeting but not another National meeting (i.e. a UK based meeting). The title of your abstract and some of the text should be changed, so it is not exactly the same as the one you presented at a National Meeting.
- Abstracts will be published in Gut. Authors of all abstracts are required to grant an exclusive licence on a worldwide basis to the BMJ and/or co-owners or contracting owning societies (where published by the BMJ on their behalf) in accordance with the BMJ & BSG licence agreement.
- No corrections to the abstract text, authors, affiliations or change of presenting author are permitted following submission. Accepted abstract presenters will have an opportunity to request modifications up until 12th April 2027. After this, abstracts will be published in Gut as submitted. Further amendments after the 12th April 2027 will not be permitted.
- Please be aware when using special characters and figures/tables that these have been saved correctly. Please ensure that all information provided is correct upon submission.
- It is the responsibility of the corresponding contact to communicate with the presenting author and co-authors, and the contact must have the permission of the co-authors to present the abstract if accepted.
- The submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) in the session and the time assigned by the BSG Programme Committee. The presenting author must register by the deadline given above to confirm that they will present at the conference. Any change of presenter must be confirmed by the withdrawal deadline.
IMPORTANT: It is not a requirement to register for the conference prior to submitting an abstract; however, if the abstract is accepted, the presenting author must register by the date confirmed in the acceptance email. Your abstract(s) will be removed from the programme and abstract book if you have not registered by then. If you require any assistance or have a query about online submission, contact [email protected]
Presentation Format
Abstracts may be submitted for consideration in one of the following categories:
- Oral, Flash poster or E-poster presentation
- E-poster presentation only
Flash Poster Presentations: Top-scoring poster abstracts may be selected for a Flash Poster Presentation, taking place during lunchtime sessions on mini stages within the exhibition hall. Presenters will have approximately 5 minutes to present 3 slides summarising their abstract and must also submit an e-poster for the online poster library.
The Programme Committee will determine the final presentation format for each accepted abstract. Decisions are final and will be communicated by the notification deadline (see Key Dates above).
Detailed presentation and e-poster guidelines will be provided following acceptance.
Abstract Topics
The abstract topic is a general heading under which the abstract will be reviewed and published. Abstracts must be submitted under the conference topic that best describes the subject of the abstract. The BSG Programme Committee reserves the right to decide on the final topic assignment of the abstract submission.
1. Endoscopy
2. Endoscopy Video
3. Inflammatory Bowel Disease
4. Liver
5. Oesophagus
6. Gastroduodenal
7. Pancreas and neuroendocrine
8. Small Bowel & Nutrition
9. Colon & Anorectal
10. Neurogastroenterology: functional disorders, motility and clinical physiology
10. Gastroenterology service: development, delivery, IT
11. Education & Training
12. Nurse
13. Pathology
14. Sustainability
Contact us
Please contact [email protected] for any queries.
Detailed Submission Guidelines
Please adhere to the guidelines when preparing abstracts. Abstracts that are not correctly formatted will not be reviewed.
How to submit an abstract
Abstracts must be submitted through the online submission platform, Oxford Abstracts. To begin, you will need to create an account and follow the simple step-by-step submission process, which will guide you through the required information.
Once registered, you can log back into your account at any time to view or edit existing submissions, or submit additional abstracts, up until the submission deadline.
Contacts
The person submitting the abstract will be designated as the abstract contact and must create an account on the online submission portal using their email address and a password. These login details should be retained for future access.
The abstract contact must provide the details of all authors, identify the presenting author and ensure that all authors have given their permission before submission.
Once an abstract has been successfully submitted, a confirmation email will be sent to the abstract contact. If no confirmation is received, please log back into the portal to check that the abstract has been fully submitted and is not still in draft.
Abstracts can be saved as drafts and edited at any time before the submission deadline (see Key Dates). Draft abstracts will not be considered for review, and no changes can be made after the deadline.
For assistance with your submission, please contact [email protected].
Steps
The online submission system will guide you through the process and ask you to provide the following information:
- Abstract details: Title, preferred presentation format (oral, flash poster or e-poster; or e-poster only) and topic.
- Author information: Names, affiliations and email addresses for all authors.
- Publication consent: Agreement to the publication of accepted abstracts in the conference app and on the website. Abstracts may be subject to editing.
- BMJ Gut Licence Agreement: Accepted abstracts will be published in a special edition of Gut (BMJ). The submitting author must confirm agreement to the BMJ’s exclusive worldwide publication licence on behalf of all co-authors and provide evidence of consent if requested. Abstracts without this agreement will not be included in the Gut publication.
- Copyright declaration: Any third-party copyrighted material must be identified, and permission obtained for BMJ and BSG to reproduce and publish it. If no restrictions apply, please state N/A. Abstracts without the necessary permissions cannot be published.
- Publication status: Confirmation that the work has not been published or accepted for publication in a peer-reviewed journal before submission.
- Conflicts of interest: Declaration of any potential conflicts of interest on behalf of all authors to ensure scientific content remains free from commercial influence or bias.
- Co-author consent: Confirmation that all co-authors have agreed to their contact details being shared with conference organisers, reviewers and session chairs/moderators for the purposes of abstract review and programme planning. Abstracts without this consent cannot be considered.
Important: Please provide a non-NHS email address for both the abstract contact and presenting author to ensure important conference communications are received and not blocked by NHS email security systems.
Abstract formatting guidelines
Abstracts must be entered directly into the text box within the online submission system. There is no abstract template to download.
Abtract structure
All abstracts must follow the structure below:
- Introduction: 1–2 sentences outlining the scientific question and its clinical or wider significance.
- Methods: A summary of the study design, analytical techniques and statistical methods used.
- Results: Objective data addressing the scientific question(s).
- Conclusions: Conclusions supported by the results, including implications for clinical practice. Avoid speculation or over-generalisation.
Formatting requirements
- Character limit: Maximum 3,000 characters, including spaces, title and any figure/table content.
- Title: Maximum 20 words and must clearly reflect the abstract’s content.
- Anonymous review: Do not include author names or affiliations in the abstract text.
- References: Must be included within the main text and count towards the character limit. Footnotes are not permitted.
- Terminology: Use generic names for drugs and therapeutic agents.
Figure and tables
A maximum of one figure or table may be included, subject to the following requirements:
- Must be in monochrome and kept as simple as possible for clear reproduction.
- Must be referenced in the abstract text as Figure 1 or Table 1.
- Figure legends and table titles must appear within the abstract text, not within the image.
- Figures will be resized to fit a single column; complex or highly detailed images are discouraged.
- Images must meet the following specifications:
- Minimum width: 83 mm
- File size: 35 KB–1,000 KB
- Resolution: Minimum 300 DPI
Please note that text within figures and tables counts towards the 3,000-character limit and may significantly reduce the space available for the main abstract.
Important publication information
Accepted abstracts will be published in Gut (BMJ), which enforces a strict 3,000-character limit. Any abstract exceeding this limit will be automatically truncated for publication, without exception.
Authors are responsible for ensuring their submission meets all formatting requirements before the deadline.
Spelling and grammar
Please ensure your abstract is free from spelling, grammatical and scientific errors, as it will be published exactly as submitted. Authors are responsible for the accuracy of their submissions, and no proofreading will be undertaken by BSG, TFI Lodestar or Gut.
- Abstracts must be submitted in English.
- Abbreviations must be defined when first used.
- Trade names may be included in both the title and main text.
- Special characters should be avoided where possible or replaced with suitable alternatives to ensure they display correctly in the published abstract.
Abstract corrections
Abstracts can be saved, edited and resubmitted as many times as required until the submission deadline of 25 January 2027. To make changes, simply log in to the submission portal and select View/Edit Abstracts.
After the submission deadline, no further edits can be made directly through the portal. However, accepted abstract presenters will have an opportunity to request amendments to the abstract text, authors, affiliations or presenting author until 12 April 2027.
Using AI to produce an abstract
The BSG recognises that the use of artificial intelligence (AI) tools such as ChatGPT or Large Language Models in research publications is expanding rapidly. As such, the BSG requires that authors who use AI tools in the preparation of an abstract or in the collection and analysis of data, must be transparent in disclosing this upon the submission of their abstract. Authors are fully responsible for the accuracy and content of their abstract, even those parts produced by an AI tool, and are thus liable for any breach of publication ethics. AI tools cannot be listed as an author of an abstract as AI tools do not meet the requirements for authorship; as non-legal entities, they cannot assert the presence or absence of conflicts of interest nor manage copyright and license agreements.
Endoscopy video submissions
BSG welcomes submissions of videos demonstrating endoscopic procedures. All videos must be accompanied by a written abstract submitted through the online submission portal.
Abstracts and their accompanying videos will be reviewed and scored together. Accepted submissions may be selected for either an oral presentation or an Endoscopy poster, with facilities available to display the video.
Video requirements
- Videos must be no longer than 5 minutes.
- Accepted formats include MPG, MP4, WMV and AVI.
- The maximum upload file size is 500 MB.
- Patient confidentiality must be maintained throughout.
- Video files must be labelled with the submitting author’s surname and the title of the accompanying abstract.
How to submit
- Submit your written abstract through the online submission portal, selecting “02. ENDOSCOPY VIDEO” as the topic.
- Upload your video directly to the submission platform (maximum 500 MB).
- If you are unable to upload your video, you may send it via WeTransfer to [email protected].
Submission deadline: 25 January 2027
Both the written abstract and accompanying video must be received by the submission deadline. Incomplete submissions will not be considered for review.
Review and notification
All abstracts will undergo blind peer review by reviewers appointed by the BSG Programme Committee.
Notification of acceptance or rejection will be sent to the abstract contact, in accordance with the published Key Dates. Information about presenter bursaries will also be provided at this stage.
Presenter registration
Presenting authors of accepted abstracts must register for the conference and pay in full by the presenter registration deadline (see Key Dates).
Accepted presenters will be eligible for the early bird registration rate until this deadline. A dedicated registration link will be included in the acceptance email and must be used to access this rate. Otherwise, the prevailing registration rate will apply.
Failure to register and pay by the deadline will result in:
- The abstract being excluded from publication in Gut.
- The abstract being withdrawn from the conference programme and all BSG-related publications.
Changes to title & text
Please ensure your abstract title and text are accurate and final before the submission deadline of 25 January 2027. Abstracts remaining in draft format will not be considered for review.
Accepted abstract presenters may request amendments until 12 April 2027. No further changes will be permitted after this date, and abstracts will be published as finalised.
Withdrawals & changes to authors
Requests to withdraw an accepted abstract must be submitted in writing to [email protected] by the withdrawal deadline (see Key Dates) to prevent publication in the Gut supplement and final conference programme.
Changes to the author list or presenting author may also be requested until this deadline. Any additions or removals of authors must have written agreement from all authors.
Requests received after the withdrawal deadline will not be accepted, and the abstract will be published in Gut as finalised.
Changes to the published abstract
It is the responsibility of the abstract submitter to check that the abstract as published in Gut supplement shortly after the conference is correct. If there is an error, this must be raised no later than 4 weeks after the conference, no changes can be made after this time.
Late breaking abstracts
SUBMIT A LATE BREAKING ABSTRACTBSG is accepting late-breaking abstracts for consideration for oral presentation only at BSG LIVE’26. Late-breaking abstract submission is strictly for abstracts advancing the field and containing late-breaking and novel data which was not available, or could not have been submitted before the general abstract submission deadline of 23rd January 2026. Abstracts will be scored on the quality and significance of the submitted evidence. BSG welcomes submissions describing new therapies and unapproved medications, large phase II or III clinical trial results, and novel basic science discoveries that have not been published or presented at other meetings. This late breaking submission period is not an extension to the general submission period. Case reports, literature reviews, retrospective studies, and abstracts featuring results or data available on the general submission deadline are ineligible. Revisions to previously submitted abstracts and abstracts that have been or will be published (including manuscripts) or presented in any other scientific venue prior to BSG LIVE’26 are also ineligible and will not be reviewed. All formatting and submission rules apply to late-breaking submissions.
FAQs
Does the BSG accept encore abstracts?
We can accept abstracts that have been presented at an International meeting but not another National meeting. Likewise, abstracts presented at the BSG can be presented at International meetings but not National ones. We also recommend changing the title of the abstract and some of the text, so it is not exactly the same.
Does the BSG accept abstracts of trials in progress or ongoing trials?
BSG will accept abstracts on trials that are ongoing, as long as the abstract includes appropriate interim results with related conclusions i.e. not stating “…results will follow.”
Are non-author presenters listed in the publication?
Only authors will be included in the publication.
Is there a dial-in option for international presenters who are not able to attend in person?
Presenting authors must attend the conference in person. The presenting author must register by the deadline given. Abstracts will be removed from the programme and from publication if the presenting author has not registered by then.
Do the BSG allow non-author presenters?
Abstract authors would always be preferred as presenters over non-author presenters. In cases where an author is not available to present, a non-author may cover the presentation. However, the non-author presenter must be familiar with the research design and findings and have a good knowledge of the subject area in order to respond to questions about the presentation even if, unlike the authors, they cannot take direct responsibility for the research. If applicable, an appropriately qualified individual from the sponsoring company (e.g. Medical Director) could present study findings if authors are not available; however, individuals with a commercial role in the sponsoring company (i.e. sales or marketing) should not act as non-author presenters.
Can industry submit an abstract?
If a HCP is unable to be listed as the lead author for an industry submitted abstract, it is recommended that an appropriately qualified individual from the company (e.g., Medical Director, MSL, Researcher) is listed as the lead author. The author(s) listed on abstracts should reflect the people who conducted the research or contributed substantially to the design of the study or to the interpretation of the results, and who were involved in the development of the presentation and are willing to take responsibility for the findings. Individuals with a commercial role in the sponsoring company (i.e., sales or marketing) should not act as authors or presenters.
Can I use artificial intelligence (AI) tools to produce my abstract?
The BSG recognises that the use of artificial intelligence (AI) tools such as ChatGPT or Large Language Models in research publications is expanding rapidly. As such, the BSG requires that authors who use AI tools in the preparation of an abstract or in the collection and analysis of data, must be transparent in disclosing this upon the submission of their abstract. Authors are fully responsible for the accuracy and content of their abstract, even those parts produced by an AI tool, and are thus liable for any breach of publication ethics. AI tools cannot be listed as an author of an abstract as AI tools do not meet the requirements for authorship; as non-legal entities, they cannot assert the presence or absence of conflicts of interest nor manage copyright and license agreements.
